Massive pulmonary thromboembolism after antifibrinolytic therapy.
Woo
K S
KS
Tse
L K
LK
Woo
J L
JL
Vallance-Owen
J
J
D000933:Antifibrinolytic Agents / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000139:chemically induced* / Q000188:drug therapy; D014148:Tranexamic Acid / Q000009:adverse effects*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D014148:Tranexamic Acid; D014568:Urokinase-Type Plasminogen Activator